Elanco Animal Health Incorporated
A maker of medicines and products for pets and farm animals, Elanco sells familiar brands like the Seresto flea-and-tick collar, the Advantage parasite treatments, and feed additives that help livestock eat more efficiently. It was born inside the drug giant Eli Lilly, which set up its animal-health work in 1954 and coined the name "Elanco" in 1960, then spun it off into an independent company in 2019. Today it sells in more than 90 countries, and even makes Bovaer, a feed ingredient that helps cattle belch less methane.
Granted 1.57M · Bought 127.0K
Granted 249.4K
Granted 243.0K
Granted 381.9K
Granted 53.5K · Bought 45.0K
Granted 135.1K
Granted 65.7K · Bought 70.0K
Granted 146.4K · Bought 9.4K
Granted 133.5K · Bought 7.0K
Granted 108.6K
Granted 65.7K · Bought 6.6K
Granted 38.5K
Granted 65.7K
Granted 65.7K
Granted 65.7K
Granted 96.8K
Granted 65.7K
Granted 99.8K
Granted 38.5K · Bought 30.0K
Granted 53.5K
Granted 65.7K
Granted 101.8K
Granted 46.3K
Granted 29.7K
Granted 13.8K
Granted 13.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR, Director · 16 transactions | — | 2.22M | 1.57M | 127.0K | — |
| Young Todd S.SEE REMARKS · 20 transactions | +42.3% | 305.7Kas of Mar 2025 | 249.4K | — | — |
| Cabral Ramiro MartinSEE REMARKS · 12 transactions | +146.8% | 283.9K | 243.0K | — | — |
| de Brabander EllenSEE REMARKS · 15 transactions | +205.9% | 280.8K | 381.9K | — | — |
| Hoover R DavidDirector · 7 transactions | +16.1% | 277.4K | 53.5K | 45.0K | — |
| Kinard David SSEE REMARKS · 12 transactions | +88.7% | 214.3K | 135.1K | — | — |
| Kurzius Lawrence ErikDirector · 9 transactions | +256.5% | 188.6K | 65.7K | 70.0K | — |
| Modi Rajeev A.SEE REMARKS · 13 transactions | +173.3% | 160.8K | 146.4K | 9.4K | — |
| VanHimbergen Robert MEVP and CFO · 3 transactions | — | 148.7K | 133.5K | 7.0K | — |
| Bettington Timothy JSEE REMARKS · 9 transactions | +32.5% | 143.3K | 108.6K | — | — |
| Harrington Michael JDirector · 7 transactions | +133.6% | 126.5K | 65.7K | 6.6K | — |
| Bilbrey John PDirector · 2 transactions | +47.2% | 120.1Kas of Dec 2024 | 38.5K | — | — |
| Anand Kapila KDirector · 5 transactions | +142.5% | 111.8K | 65.7K | — | — |
| Garcia Art ADirector · 5 transactions | +154.9% | 108.2K | 65.7K | — | — |
| McDonald Kirk PDirector · 5 transactions | +164.9% | 105.6K | 65.7K | — | — |
| McArdle GraceEVP, MANUFACTURING AND QUALITY · 16 transactions | +363.4% | 103.7K | 96.8K | — | — |
| Herendeen PaulDirector · 5 transactions | +182.8% | 101.7K | 65.7K | — | — |
| Correia de Simas Jose ManuelSEE REMARKS · 12 transactions | +161% | 101.0K | 99.8K | — | — |
| Doyle William FDirector · 4 transactions | +264.1% | 94.5Kas of Nov 2024 | 38.5K | 30.0K | — |
| Kochevar Deborah TurnerDirector · 4 transactions | +131% | 94.4K | 53.5K | — | — |
| Scots-Knight DeniseDirector · 5 transactions | +134.3% | 93.4K | 65.7K | — | — |
| O'Neill ShivGC AND CORP SEC · 12 transactions | — | 83.8K | 101.8K | — | — |
| Meer James MCHIEF ACCOUNTING OFFICER · 16 transactions | +59.9% | 66.7K | 46.3K | — | — |
| Ma StaceyDirector · 4 transactions | — | 17.5K | 29.7K | — | — |
| Turner Kathy VDirector · 1 transaction | — | 13.8Kas of Nov 2024 | 13.8K | — | — |
| Wallace Craig S.Director · 1 transaction | — | 13.8Kas of Nov 2024 | 13.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +294.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.